Royal Bank of Canada’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $53.2M | Sell |
100,428
-23,501
| -19% | -$10.8M | 0.01% | 958 |
|
|
2026
Q1 | $59.5M | Buy |
123,929
+3,961
| +3% | +$2.03M | 0.01% | 839 |
|
|
2025
Q4 | $67.4M | Sell |
119,968
-39,069
| -25% | -$22.2M | 0.01% | 820 |
|
|
2025
Q3 | $81.8M | Buy |
159,037
+35,463
| +29% | +$15.5M | 0.01% | 784 |
|
|
2025
Q2 | $38.8M | Buy |
123,574
+74,842
| +154% | +$22.5M | 0.01% | 1089 |
|
|
2025
Q1 | $14.8M | Buy |
48,732
+334
| +0.7% | +$112K | ﹤0.01% | 1500 |
|
|
2024
Q4 | $16.1M | Buy |
48,398
+890
| +2% | +$302K | ﹤0.01% | 1498 |
|
|
2024
Q3 | $15.9M | Buy |
47,508
+1,627
| +4% | +$618K | ﹤0.01% | 1495 |
|
|
2024
Q2 | $18.9M | Sell |
45,881
-129,959
| -74% | -$51.5M | ﹤0.01% | 1278 |
|
|
2024
Q1 | $71.1M | Sell |
175,840
-43,359
| -20% | -$15.2M | 0.02% | 647 |
|
|
2023
Q4 | $67.2M | Sell |
219,199
-3,778
| -2% | -$1.02M | 0.02% | 654 |
|
|
2023
Q3 | $54M | Sell |
222,977
-15,011
| -6% | -$3.84M | 0.01% | 668 |
|
|
2023
Q2 | $57.2M | Buy |
237,988
+19,276
| +9% | +$4M | 0.02% | 656 |
|
|
2023
Q1 | $41.1M | Sell |
218,712
-15,065
| -6% | -$3.12M | 0.01% | 761 |
|
|
2022
Q4 | $49.7M | Sell |
233,777
-19,303
| -8% | -$3.86M | 0.01% | 687 |
|
|
2022
Q3 | $39.8M | Sell |
253,080
-2,362
| -0.9% | -$377K | 0.01% | 735 |
|
|
2022
Q2 | $38.2M | Buy |
255,442
+10,386
| +4% | +$1.5M | 0.01% | 772 |
|
|
2022
Q1 | $40.1M | Sell |
245,056
-2,248
| -0.9% | -$371K | 0.01% | 843 |
|
|
2021
Q4 | $53.8M | Buy |
247,304
+2,941
| +1% | +$616K | 0.01% | 773 |
|
|
2021
Q3 | $46.3M | Buy |
244,363
+457
| +0.2% | +$83.4K | 0.01% | 792 |
|
|
2021
Q2 | $43.1M | Sell |
243,906
-6,595
| -3% | -$1.14M | 0.01% | 837 |
|
|
2021
Q1 | $41.1M | Sell |
250,501
-11,670
| -4% | -$1.78M | 0.01% | 799 |
|
|
2020
Q4 | $36.5M | Sell |
262,171
-1,810
| -0.7% | -$228K | 0.01% | 860 |
|
|
2020
Q3 | $29.5M | Sell |
263,981
-50,819
| -16% | -$5.88M | 0.01% | 847 |
|
|
2020
Q2 | $29.3M | Buy |
314,800
+18,543
| +6% | +$1.58M | 0.01% | 816 |
|
|
2020
Q1 | $21.7M | Buy |
296,257
+9,144
| +3% | +$794K | 0.01% | 862 |
|
|
2019
Q4 | $24.1M | Buy |
287,113
+2,476
| +0.9% | +$192K | 0.01% | 1035 |
|
|
2019
Q3 | $23.9M | Sell |
284,637
-5,025
| -2% | -$380K | 0.01% | 963 |
|
|
2019
Q2 | $19M | Sell |
289,662
-54,206
| -16% | -$3.12M | 0.01% | 1130 |
|
|
2019
Q1 | $20.3M | Sell |
343,868
-11,279
| -3% | -$674K | 0.01% | 1052 |
|
|
2018
Q4 | $18.8M | Buy |
355,147
+331,921
| +1,429% | +$18.2M | 0.01% | 1028 |
|
|
2018
Q3 | $1.39M | Buy |
23,226
+16,973
| +271% | +$928K | ﹤0.01% | 3118 |
|
|
2018
Q2 | $269K | Buy |
6,253
+12
| +0.2% | +$485 | ﹤0.01% | 4232 |
|
|
2018
Q1 | $218K | Sell |
6,241
-583
| -9% | -$21.3K | ﹤0.01% | 4276 |
|
|
2017
Q4 | $248K | Buy |
6,824
+6,286
| +1,168% | +$220K | ﹤0.01% | 4287 |
|
|
2017
Q3 | $17K | Sell |
538
-395
| -42% | -$12.1K | ﹤0.01% | 6030 |
|
|
2017
Q2 | $27K | Buy |
933
+11
| +1% | +$309 | ﹤0.01% | 5424 |
|
|
2017
Q1 | $28K | Sell |
922
-83
| -8% | -$2.68K | ﹤0.01% | 5454 |
|
|
2016
Q4 | $36K | Buy |
1,005
+805
| +403% | +$26.8K | ﹤0.01% | 5444 |
|
|
2016
Q3 | $6K | Buy |
+200
| New | +$5.84K | ﹤0.01% | 5924 |
|
Other funds holding MEDP
WA
Royal Bank of Canada's MEDP Position: Q2 2026 in Review
Royal Bank of Canada reduced its Medpace (MEDP) stake by 19% in Q2 2026, selling an estimated $10.8M and leaving 100,428 shares worth $53.2M. The position accounts for 0.01% of the portfolio, ranked #958.
Royal Bank of Canada first reported a position in MEDP in Q3 2016 and has held it in 40 quarters since. The position peaked at $81.8M in Q3 2025. 693 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.
- Royal Bank of Canada held 100,428 shares of Medpace worth $53.2M as of Q2 2026.
- Royal Bank of Canada sold 23,501 Medpace shares in Q2 2026, an estimated $10.8M.
- Medpace made up 0.01% of Royal Bank of Canada's portfolio in Q2 2026, its #958 holding.
- Royal Bank of Canada first reported a position in Medpace in Q3 2016 and has held it in 40 quarters since.
- Royal Bank of Canada's Medpace position peaked at $81.8M in Q3 2025.
- 693 funds tracked by Wall St. Rank held Medpace as of Q2 2026.
Based on Royal Bank of Canada's 13F filing for Q2 2026, filed 14 Aug 2026.